POST Online Media Lite Edition


AuraSense Therapeutics names CFO

Staff writer |
Skokie, Ill., USA - July 24, 2014, Skokie, Ill., USA - AuraSense Therapeutics, a biotechnology company, announced that David Snyder has joined AuraSense Therapeutics' executive leadership team as chief financial officer.

Article continues below

Prior to joining AuraSense Therapeutics, Mr. Snyder was Executive Vice President and Chief Financial Officer of Cellular Dynamics International Inc., where he was responsible for all financial functions, human resources, and general administration. Snyder helped lead CDI's successful IPO in July of 2013.

He previously served as senior vice president of finance, site vice president and chief financial officer of Roche NimbleGen from 2007 to 2008. From 2006 to 2007, he served as vice president and chief financial officer of NimbleGen Systems, Inc.

Prior to NimbleGen, he held various leadership positions in software, real estate, and diversified manufacturing industries. He has served as a director of Invenra, Inc. since 2012. He has also served on the Board of Trustees of Ottawa University since 2012.


What to read next

Mirna Therapeutics appoints Paul Lammers as president and CEO
Silence Therapeutics appoints David Ellam as CFO
Mission Therapeutics appoints non-executive chairman